Biocardia Dividends
| BCDA Stock | USD 1.09 0.07 6.03% |
As of February 4, 2026, Dividends Paid is expected to decline to about 378 K. In addition to that, Dividend Yield is expected to decline to 0.03. Biocardia's past performance could be the main factor of why investors trade Biocardia stock today. Investors should clearly understand every aspect of the Biocardia dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Biocardia's dividend schedule and payout information. Biocardia dividends can also provide a clue to the current valuation of Biocardia.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 397.9 K | 378 K | |
| Dividend Yield | 0.03 | 0.03 | |
| Dividend Payout Ratio | (0.96) | (1.01) | |
| Dividend Paid And Capex Coverage Ratio | -1.5 K | -1.5 K |
Biocardia | Build AI portfolio with Biocardia Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Biocardia must own a stock before its ex-dividend date to receive its next dividend.
Biocardia Dividends Paid Over Time
Today, most investors in Biocardia Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biocardia's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Biocardia dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Biocardia Historical Dividend Yield Growth
A solid dividend growth pattern of Biocardia could indicate future dividend growth is likely, which can signal long-term profitability for Biocardia. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Biocardia dividend as a percentage of Biocardia stock price. Biocardia dividend yield is a measure of Biocardia stock productivity, which can be interpreted as interest rate earned on an Biocardia investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. Projected growth potential of Biocardia fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biocardia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Biocardia requires distinguishing between market price and book value, where the latter reflects Biocardia's accounting equity. The concept of intrinsic value - what Biocardia's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Biocardia's price substantially above or below its fundamental value.
It's important to distinguish between Biocardia's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biocardia should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biocardia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.